The Financial Horizons
No Result
View All Result
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
  • Latest News
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
  • Latest News
No Result
View All Result
The Financial Horizons
No Result
View All Result
Home Latest News

The White House has a pharmacy – and it was a mess, a new investigation found

by
January 24, 2024
in Latest News
0
The White House has a pharmacy – and it was a mess, a new investigation found
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter
Join Fox News for access to this content
Plus get unlimited access to thousands of articles, videos and more with your free account!
Please enter a valid email address.
By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your email and follow the instructions provided.

A new Defense Department inspector general report reveals that a little-known in-house pharmacy at the White House erroneously dolled out prescription medications to staff and wasted $750,000 in taxpayer money.

One former pharmacy staff member told investigators that a doctor once asked if the staffer could ‘hook up’ someone with a controlled substance ‘as a parting gift for leaving the White House.’

The report, according to an article in Stat News, revealed that the pharmacy office dispensed controlled medications like Ambien and Provigil without verifying the patient’s identity.

Stat reported that in an office in the White House there was a sign that read ‘Pharmacy,’ but the people in charge of it insisted it wasn’t actually one.

The investigation, which was published this month, was conducted by the Department of Defense’s independent Office of the Inspector General as the White House pharmacy is run by the White House Military Office and its associated medical unit. 

The probe was prompted by internal complaints the DOD received in 2018 about a senior military medical officer, who is not named, engaging in ‘improper medical practices.’ It covers only activity in the office through early 2020 under the Trump administration, but investigators interviewed staffers who also worked there under former President Obama, according to Stat.

According to the report, the ‘pharmacy’ let people grab over-the-counter medicines from open bins.

It also found that a larger affiliate of the office inappropriately covered care for a whole host of personnel who weren’t eligible, costing more than $750,000 in wasted taxpayer funds in just three years. Stat notes that even that number is ‘fuzzy’ because so many records were poorly kept and even handwritten.

‘If this had been a traditional pharmacy, they certainly would have been cited by their state board of pharmacy,’ Douglas Hoey, CEO of the National Community Pharmacists Association, told the outlet. ‘And there’s probably even an outside chance that they’d be shut down by their state board of pharmacy, if this was a pharmacy operating outside of the cocoon of the White House.’.

This post appeared first on FOX NEWS
Previous Post

McConnell says NH primary of ‘great interest’ but declines to endorse Trump amid mounting pressure

Next Post

Hunter Biden’s ‘sugar brother’ lawyer confirms he still holds stake in Chinese state-backed equity fund

Next Post
Hunter Biden’s ‘sugar brother’ lawyer confirms he still holds stake in Chinese state-backed equity fund

Hunter Biden’s ‘sugar brother’ lawyer confirms he still holds stake in Chinese state-backed equity fund

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent News

    Obama reacts to Biden diagnosis: ‘Nobody has done more to find breakthrough treatments for cancer…than Joe’

    Obama reacts to Biden diagnosis: ‘Nobody has done more to find breakthrough treatments for cancer…than Joe’

    May 19, 2025
    Trump reshapes US foreign policy with wildly successful, business-first Middle East trip

    Trump reshapes US foreign policy with wildly successful, business-first Middle East trip

    May 19, 2025
    Trump’s ‘big, beautiful bill’ passes key House hurdle after GOP rebel mutiny

    Trump’s ‘big, beautiful bill’ passes key House hurdle after GOP rebel mutiny

    May 19, 2025
    Iran foreign minister vows nuclear enrichment will continue ‘with or without a deal’

    Iran foreign minister vows nuclear enrichment will continue ‘with or without a deal’

    May 19, 2025
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: Thefinancialhorizons.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 thefinancialhorizons.com | All Rights Reserved

    No Result
    View All Result
    • Investing
    • Stock
    • Economy
    • Editor’s Pick
    • Latest News

    Disclaimer: Thefinancialhorizons.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 thefinancialhorizons.com | All Rights Reserved